A detailed history of Td Capital Management LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Td Capital Management LLC holds 47 shares of OCUL stock, worth $346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47
Holding current value
$346
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$5.93 - $9.08 $278 - $426
47 New
47 $0

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $568M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Td Capital Management LLC Portfolio

Follow Td Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Capital Management LLC with notifications on news.